Christoph Broja
Partner @ EQT Life Sciences
Christoph Broja is a Series C investor at EQT Life Sciences focused on Health Care and Biotechnology. Christoph Broja is based out of Germany, and is the a Partner at EQT Life Sciences. Christoph previously served as the Board Observer at Electra Therapeutics. Christoph Broja attended Friedrich Schiller University Jena. Christoph Broja is a certified Chartered Financial Analyst.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Christoph Broja invests in
Stages Christoph Broja invests in
Countries Christoph Broja invests in
Investment Focus
Industry
- Health Care 2 (100%)
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Life Science 1 (50%)
- Therapeutics 1 (50%)
Stage
- Series C 2 (100%)
- Series B 1 (50%)
Country
- Germany 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Electra Therapeutics
|
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases. | $183M / Series C / Oct 22, 2025 | |
Tubulis
|
Tubulis is a biotechnology company that develops antibody-drug conjugates (ADCs) for targeted cancer therapy. The company combines proprietary technologies with disease-specific biological insights to create highly stable and effective protein-drug conjugates. Its platform enables the design of ADCs with improved delivery, reduced toxicity, andenhanced therapeutic potential across various cancer types, including solid and hematologic tumors. Tubulis is advancing a pipeline of experimental drug candidates, such as TUB-040 and TUB-030, which are currently being evaluated in clinical settings for cancers like ovarian and lung cancer. The company also collaborates with industry partners and leverages its proprietary conjugation technologies to expand the scope and effectiveness of targeted oncology treatments. | $139.3M / Series B / Mar 14, 2024 |
Co-Investors
About EQT Life Sciences
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
EQT Life Sciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Christoph Broja
Partner
|
|||
Fouad Azzam
General Partner
|
|||
Joachim Rothe
General Partner
|
|||
Daniela Begolo
Managing Director
|
|||
|
Ellen Cordo
Chief Finance
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Christoph Broja invest in?
Christoph Broja invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Series B stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Christoph Broja last invest?
The most recent investment recorded for Christoph Broja closed in Oct 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
